All India articles – Page 7
-
FeatureIndia’s chemistry challenges
India’s climate, its vast population and extremely rapid development make it host to a unique set of challenges. Sanjay Kumar finds out how Indian chemists are developing home-grown solutions
-
OpinionBright lights and dark shadows
India is a place of contrast, where beacons of innovation highlight significant societal challenges
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
CareersSuccour for India's struggling scientists
The Right to Research foundation is helping Indian researchers to work their way into a job, as Rajesh Parishwad finds out
-
BusinessIndian manufacturers hit back over quality claims
Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers
-
NewsTussle over four-year science degrees in India
Government wants universities to return to three-year degrees to annoyance of top institutes
-
Business
Piramal exits drug discovery in India
Company will concentrate on generic medicines and clinical and contract research.
-
BusinessPrice caps provoke lawsuits from Indian pharma industry
New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups
-
NewsIndian scientists applaud research budget
Fears that the government would cut science funding proved unfounded as more money is made available
-
NewsIndian scientists call for commitment to science
Modi’s government will need to tackle problems of underinvestment and broken promises that have plagued Indian research for years
-
Business
AstraZeneca ends R&D in India
Bangalore site will close with loss of 168 jobs. Some projects will transfer to UK
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
News
Radical drug rule changes hit buffers in India
Oversight panel concludes government plan will increase bureaucracy
-
FeatureGeneric problems
The Indian pharmaceutical industry has been hit by recent problems. Angeli Mehta investigates
-
News
Rough patch for India’s clinical trial industry
Bad publicity has added to the woes of an industry worried by regulatory uncertainty
-
News
Supreme court ruling brings clinical trials to a halt in India
Pressure from campaign group precipitates action that puts 162 drug trials on ice
-
NewsAnother drug suspension overturned in India
Safety concerns put sales of antidepressant Deanxit on ice until firms petitioned a high court
-
NewsIndian U-turn on diabetes drug ban
Suspension of cheap and popular medicine reversed but will now come with new safety warnings
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec